ASSET SELECTION & PROTECTED CULTURE
The nutraceutical raw materials market is plagued by a structural conflict of interest. In fact, many suppliers self-certify the quality of their extracts using their own certificates.
This self-validation creates a direct bias. Our comparative analyses of multiple batches reveal recurring discrepancies between supplier certificates and the results of independent laboratories regarding the actual active ingredient content and the presence of contaminants.
We select only raw materials whose quality stands up to independent, rigorous, and reproducible testing.
A LITTLE HISTORY
We reject any validation provided by the supplier itself.
We exclude laboratories affiliated with manufacturers.
We reject analytical methods that favor the supplier.
We select only raw materials whose quality stands up to independent, rigorous, and reproducible testing.
A PROTECTED WEALTH
We engage independent, reputable laboratories that are ISO 17025-accredited.
Every batch received undergoes a comprehensive analysis: identity, active ingredient concentration, heavy metals, pesticides, and microbiological contaminants. No batch enters production without proper validation.
We publish the full results of each batch analysis. Some products have more than 400 publicly available cumulative analyses.
Given these high standards, many suppliers fail to pass the qualification phase. Incomplete applications, inadequate analytical methods, and a lack of demonstrated consistency. Ultimately, nearly nine out of ten suppliers are not selected.
